Veterinary Medicines

LEVISOLE TRANSCUTANE

Not authorised
  • Levamisole
Download as PDF

Product identification

Medicine name:
LEVISOLE TRANSCUTANE
Active substance:
  • Levamisole
Target species:
  • Cattle
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Levamisole
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Pour-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma S.A.
Responsible authority:
  • ANSES
Authorisation number:
  • FR/V/1870548 3/1986
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."